Mycro3D

Cover Block

PUBLIC

Name	Mycro3D ApS
Tagline	Microscale 3D printing as a service for ultra-precise components in R&D and product development.
Headquarters	Lyngby, Denmark
Founded	2022
Stage	Pre-Seed
Business Model	B2B
Industry	Deeptech
Technology	Hardware
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Academic Spinout

Links

PUBLIC

• Website: https://mycro3d.com/
• LinkedIn: https://www.linkedin.com/company/mycro3d/

Executive Summary

PUBLIC Mycro3D offers microscale, high-resolution 3D printing as a service, positioning itself as a capital-light bridge between advanced academic research and commercial prototyping in high-value sectors like medtech and microfluidics [mycro3D, retrieved 2024]. The company is a spin-out from the Technical University of Denmark (DTU), specifically from the Section for Innovation and Digital Health (IDUN) at DTU Health Tech, which provides a foundation of technical credibility and access to specialized equipment [DTU Health Tech, c. 2023-2024]. Its service model is the primary differentiator, allowing clients to access ultra-precise fabrication for micro-features without the prohibitive capital expenditure of in-house systems [Perplexity Sonar Pro Brief, retrieved 2024]. The founding team is not publicly named, but the academic origin suggests deep technical expertise in microfabrication, though commercial go-to-market experience remains an open question. No venture funding rounds have been announced, indicating a bootstrapped or internally funded early stage; the business model relies on service revenue from projects with companies and research organizations. Over the next 12-18 months, the key signals to monitor will be the public disclosure of named commercial customers beyond the noted collaboration with Prirevo, any formal venture capital raise, and the articulation of a scalable sales motion beyond its DTU network [LinkedIn, October 2024].

Data Accuracy: YELLOW -- Core business description and academic origin are confirmed, but key details like founders and funding are not publicly available.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Deeptech
Technology Type	Hardware
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Academic Spinout

Company Overview

PUBLIC

Mycro3D was formed in 2022 as a spin-out from the Technical University of Denmark (DTU), specifically from the Section for Innovation and Digital Health (IDUN) within DTU Health Tech [DTU Health Tech, c. 2023-2024]. The company’s origin as an academic venture provides its foundational credibility, positioning it to commercialize research-grade microscale 3D printing technology for industrial and R&D applications. It is registered as Mycro3D ApS, a private limited company, with its headquarters located at Diplomvej 381 in Lyngby, Denmark, placing it within the DTU Science Park ecosystem [Kompass, retrieved 2024].

Since its founding, the company’s public milestones have been limited, reflecting its early-stage, research-focused nature. The most recent public signal of commercial activity is a LinkedIn post from October 2024, in which Jens Friholm, CEO of Austrian 3D printing service provider Prirevo, praised Mycro3D’s “impressive technology” and highlighted a successful project using its high-resolution printing service [LinkedIn, October 2024]. This serves as an indicator of external validation and partnership, though formal customer case studies or major contract announcements have not been published.

Data Accuracy: YELLOW -- Company spin-out status and HQ confirmed by DTU and directory sources; commercial activity corroborated by a single external post.

Product and Technology

MIXED

The core offering is a service-based access point to high-precision additive manufacturing at the microscale, a niche defined by its technical constraints rather than a specific printer model. Mycro3D positions itself as a bridge for R&D teams and product developers who need ultra-precise components but lack the capital or expertise to invest in the required hardware and process development [mycro3D, retrieved 2024]. The company's public materials emphasize versatility and affordability, framing the service as a way to implement micro-features without compromising on quality [Perplexity Sonar Pro Brief, retrieved 2024].

Technologically, the service appears anchored in two-photon polymerization (2PP), a process capable of producing features at the sub-micron level, which is a standard for the high-end micro 3D printing segment [MDPI, 2022]. The company's website notes the use of G-code for printer operation, a common control language that suggests a degree of process customization and repeatability for clients [mycro3D, retrieved 2026]. Target applications cited publicly include medtech devices, microfluidics, MEMS (Micro-Electro-Mechanical Systems), and sensor prototyping, all fields where miniaturization and complex internal geometries are critical [Perplexity Sonar Pro Brief, retrieved 2024].

• Service model. The business is structured as a service, providing printed components rather than selling printers. This reduces the client's upfront capital expenditure and technical barrier to entry.
• Academic foundation. As a spin-out from DTU, the company's technical credibility is implicitly tied to the university's research in digital health and microfabrication, though the specific proprietary advancements are not detailed publicly [DTU Health Tech, c. 2023-2024].
• External validation. A partnership-level relationship is evidenced by a LinkedIn post from Jens Friholm of Prirevo, an Austrian 3D printing service bureau, which praised Mycro3D's "impressive technology" and "ultra-precise" results for product development [LinkedIn, October 2024].

The product surface, as described, is deliberately narrow. There is no public mention of proprietary software, material formulations, or post-processing techniques that would constitute a defensible moat beyond the service execution itself. The company's aim to "make micro- and nanoscale manufacturing accessible" suggests a focus on democratization through service, but the technical roadmap and any planned IP development are not disclosed [mycro3D, retrieved 2024].

Data Accuracy: YELLOW -- Core service description is confirmed by the company's own website and an external partner's testimonial. Specific technical parameters and proprietary elements are not detailed.

Market Research

PUBLIC The demand for microscale manufacturing is being pulled by industries where smaller, more complex, and more integrated components are becoming a prerequisite for next-generation products.

Available public reports do not provide a specific total addressable market (TAM) figure for microscale 3D printing as a service. The broader additive manufacturing market provides an analog. According to a 2023 report from 3Dnatives, the global 3D printing market was valued at approximately $18 billion (estimated) and is projected to grow to over $40 billion by 2027 [3Dnatives, 2023]. The high-resolution and micro-scale segment, while a niche within this total, is often cited as one of the fastest-growing due to its applications in advanced R&D. For context, the microfluidics market alone, a key application area, is projected to reach $12.5 billion by 2026 according to a separate industry analysis cited by Formnext [Formnext, retrieved 2026].

Demand is driven by several converging trends. The miniaturization of electronics, medical devices, and sensors requires fabrication techniques capable of producing features measured in microns. Academic and industrial R&D labs, which may lack the capital for multi-million-dollar in-house systems, represent a serviceable addressable market for on-demand access. Furthermore, the push for rapid prototyping in fields like medtech and micro-electromechanical systems (MEMS) creates a need for faster iteration cycles than traditional micro-fabrication methods like lithography can provide [MDPI, 2022].

Adjacent and substitute markets highlight both the opportunity and the competitive pressure. Traditional precision machining and photolithography remain the incumbent technologies for mass production of micro-components. The value proposition of additive techniques like two-photon polymerization (2PP) is not volume production but design freedom, speed for prototypes, and the ability to create complex internal geometries impossible with subtractive methods [Nanoscribe, retrieved 2026]. The service model also competes with capital expenditure decisions, where a company must weigh the cost of outsourcing against purchasing and maintaining proprietary equipment.

Regulatory and macro forces are generally favorable but carry nuance. In regulated sectors like medtech, any component used in a final device must be produced under appropriate quality management systems, which could be a barrier for a service provider but also a moat once established. Geopolitical trends toward supply chain resiliency and onshoring advanced manufacturing could benefit regional service providers in Europe. However, the sector remains capital-intensive for technology developers, relying on continued R&D investment from both private companies and academic institutions to advance the underlying print technology and materials libraries.

Global 3D Printing Market (2023) | 18 | $B
Projected Market (2027) | 40 | $B
Microfluidics Market (Projected 2026) | 12.5 | $B

The available sizing data, while not specific to Mycro3D's niche, illustrates the growth trajectory of the broader additive manufacturing ecosystem and the substantial scale of one of its target application markets. The serviceable market for micro-scale printing is a fraction of these totals, but positioned within a high-value, expanding segment.

Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party industry reports and provide a relevant analog, but a dedicated TAM for micro-scale 3D printing services is not publicly quantified.

Competitive Landscape

MIXED Mycro3D’s competitive position is defined by its academic service model, which carves a narrow path between large-scale industrial 3D printing bureaus and capital-intensive hardware vendors.

A direct, named competitor for Mycro3D is not present in public sources, which is itself a signal of the company's niche focus. The competitive map is therefore best understood by segment. In the broad market for 3D printing services, large-scale digital manufacturing bureaus like Protolabs and Shapeways offer a vast range of materials and technologies but are not optimized for the sub-100-micron resolution and specialized consultation Mycro3D targets [3Dnatives, 2023]. At the opposite end are the hardware manufacturers of high-resolution micro 3D printers, such as Nanoscribe (a leader in two-photon polymerization systems) and Boston Micro Fabrication (BMF) [MDPI, 2022] [Formnext]. These companies sell expensive capital equipment, often priced above €250,000, creating a significant barrier for research labs and small product development teams. Mycro3D’s service model is a direct substitute for this capital expenditure.

Where Mycro3D has a defensible edge today is its deep integration with the Technical University of Denmark's (DTU) research ecosystem. This provides access to specialized equipment, academic expertise in microfabrication, and a pipeline of early-adopter users from within the university's network [DTU Health Tech, c. 2023-2024]. This edge is perishable, however. It depends on maintaining exclusive or preferential access to DTU resources and does not constitute a proprietary technology barrier. The durability of this advantage will be tested if the company scales and must invest in its own, non-university infrastructure.

The company is most exposed to competition from other academic spin-outs or specialized service bureaus that decide to enter the micro-printing-as-a-service niche. A competitor like Prirevo, the Austrian 3D printing service provider whose CEO publicly praised Mycro3D’s work, could use its existing commercial relationships and broader service portfolio to add micro-printing capabilities, negating Mycro3D’s specialist focus [LinkedIn, October 2024]. Furthermore, Mycro3D’s lack of a proprietary hardware platform means its service quality and cost are ultimately tied to commercially available printer technology, leaving it vulnerable to margin pressure from hardware vendors who might eventually offer their own service arms.

The most plausible 18-month scenario involves consolidation of niche expertise. If the demand for micro-scale prototyping in European medtech and microelectronics accelerates, a winner could be a service bureau that successfully aggregates multiple high-resolution technologies under one commercial roof. In that case, Mycro3D’s deep academic ties might make it an attractive acquisition target for a larger player seeking instant capability and credibility. Conversely, a loser in this scenario would be any pure-service player that fails to move beyond project-based work to secure recurring, high-volume design partnerships with industrial customers, remaining perpetually reliant on low-margin, one-off academic projects.

Data Accuracy: YELLOW -- Competitive analysis is inferred from market reports and adjacent company profiles; no direct competitor data is publicly available for Mycro3D.

Opportunity

PUBLIC The prize for Mycro3D is becoming the de facto service provider for rapid, high-precision microscale prototyping across advanced European R&D sectors, a role that could command premium pricing and recurring enterprise contracts.

The headline opportunity is to become the default outsourced partner for micro- and nanoscale additive manufacturing in Europe, akin to a specialized, high-end contract research organization for physical prototypes. The evidence for this reachable outcome, rather than an aspirational one, lies in the company's foundational position within a major technical university and the clear, unmet need it addresses. Mycro3D is a spin-out from the Technical University of Denmark (DTU), specifically from its Health Tech department [DTU Health Tech, c. 2023-2024]. This grants it inherent credibility and a pipeline into academic and early-stage industrial projects that require the kind of ultra-precise components it produces for medtech, microfluidics, and sensor prototyping [Perplexity Sonar Pro Brief, retrieved 2024]. The business model is service-based, which removes the massive capital barrier for clients to access this capability. If the company can consistently deliver on its promise of "versatile solutions for microscale 3D printing at an affordable cost" [mycro3D, retrieved 2024], it positions itself not just as a vendor but as a critical extension of its clients' R&D teams.

Growth is likely to follow one of several concrete paths, each with a distinct catalyst.

Scenario	What happens	Catalyst	Why it's plausible
The Medtech Wedge	Mycro3D becomes the go-to prototyping service for European medtech startups and research hospitals, leading to embedded, multi-year development partnerships.	A formal, publicized partnership with a major university hospital or a medtech accelerator program.	The company originated in DTU Health Tech, placing it directly in the medtech innovation ecosystem [DTU Health Tech, c. 2023-2024]. External validation exists via a LinkedIn post from the CEO of Prirevo, a 3D printing service company, praising a collaboration [LinkedIn, October 2024].
The Industrial Design Partner	The company expands beyond pure R&D to become a critical supplier for final, low-volume production parts in micro-optics, MEMS, and bespoke sensor housings.	Securing a contract for a small-batch production run (hundreds to thousands of units) with a named industrial customer.	The technology cited, two-photon polymerization, is recognized for enabling direct fabrication of functional micro-parts beyond just prototypes [MDPI, 2022]. The service model is inherently scalable for low-volume manufacturing.

What compounding looks like is a classic expertise and reputation flywheel. Each successful project, particularly in a demanding field like in-vitro diagnostics or micro-optics, adds to a proprietary library of design-for-manufacturability knowledge at the microscale. This accumulated process intelligence becomes a data moat, allowing Mycro3D to quote more accurate timelines, achieve higher first-pass success rates, and tackle increasingly complex geometries that new entrants cannot. Early signs of this flywheel starting are visible in the social proof from an industry peer, which serves as a reputational signal to other potential clients [LinkedIn, October 2024]. As the portfolio of completed projects grows, so does the case-study evidence needed to land larger, more strategic contracts, locking in customers through demonstrated competency rather than just price.

The size of the win can be framed by looking at a credible comparable. Nanoscribe, a German leader in high-precision 3D microprinting systems, was acquired by CELLINK (now BICO) in 2021 for an initial €50 million, with potential earn-outs [various industry reports]. While Nanoscribe is a hardware manufacturer and Mycro3D is a service provider, the valuation reflects the strategic premium placed on mastering microfabrication technology. If Mycro3D successfully executes on the "Medtech Wedge" scenario and captures a meaningful share of the European contract prototyping market for such components, a strategic acquisition by a larger life sciences tools company or a specialty manufacturing group in the €20-50 million range is a plausible outcome (scenario, not a forecast). This represents a significant multiple on any early-stage investment in a capital-light, expertise-driven service model.

Data Accuracy: YELLOW -- The core opportunity thesis is built on the company's stated service model and academic origin, which are confirmed. Growth scenarios and the size of the win are extrapolated from these foundations and a single external validation point; specific customer traction or financial metrics to corroborate the flywheel are not publicly available.

Sources

PUBLIC

1. [mycro3D, retrieved 2024] mycro3D | https://mycro3d.com/

2. [DTU Health Tech, c. 2023-2024] We create new businesses | https://www.healthtech.dtu.dk/research/research-sections/section-idun/creating-new-businesses

3. [Perplexity Sonar Pro Brief, retrieved 2024] What Mycro3D does | https://mycro3d.com/about/

4. [LinkedIn, October 2024] LinkedIn post by Jens Friholm | https://www.linkedin.com/posts/jens-friholm-3433a72_great-work-mycro3d-impressive-technology-activity-7404091151454187520-f0or

5. [Kompass, retrieved 2024] Mycro3D ApS - Plastic products NES, Lyngby | https://in.kompass.com/c/mycro3d-aps/dkk587458/

6. [mycro3D, retrieved 2026] Contact - mycro3D | https://mycro3d.com/contact/

7. [MDPI, 2022] Micro 3D Printing by Two-Photon Polymerization: Configurations and Parameters for the Nanoscribe System | https://www.mdpi.com/2673-8023/1/2/13

8. [3Dnatives, 2023] The Best Micro 3D Printing Solutions On the Market - 3Dnatives | https://www.3dnatives.com/en/the-best-micro-3d-printing-solutions-19012023/

9. [Formnext, retrieved 2026] Micro 3D Printing: From precision prototypes to scaled-down production | https://formnext.mesago.com/frankfurt/en/industry-insights/fonmag/fonmag_articles_new/Micro-3D-Printing.html

10. [Nanoscribe, retrieved 2026] Two-Photon Polymerization (2PP) 3D printing | https://www.nanoscribe.com/en/microfabrication-technologies/2pp-two-photon-polymerization/